Search

Your search keyword '"Chinnaiyan, Arul"' showing total 3,424 results

Search Constraints

Start Over You searched for: Author "Chinnaiyan, Arul" Remove constraint Author: "Chinnaiyan, Arul"
3,424 results on '"Chinnaiyan, Arul"'

Search Results

1. Germline loss-of-function variant in the E3 ubiquitin ligase TRAF2 in a young adult patient with medulloblastoma: a case report.

2. CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13.

4. A Systematic Overview of Single-Cell Transcriptomics Databases, their Use cases, and Limitations

5. NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis

8. PIKfyve, expressed by CD11c-positive cells, controls tumor immunity

9. Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis

10. Reply to “Contextualizing racial associations in prostate cancer to expose structural causes”

11. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

12. Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy

15. Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.

16. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

19. Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition

21. Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance

22. Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies

25. Multi-scale signaling and tumor evolution in high-grade gliomas

27. Comprehensive proteogenomic characterization of rare kidney tumors

28. Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance

30. Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas

31. Pan-cancer proteogenomics characterization of tumor immunity

33. Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

35. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

36. Proteogenomic insights suggest druggable pathways in endometrial carcinoma

37. Accelerating precision medicine in metastatic prostate cancer

38. The DNA methylation landscape of advanced prostate cancer

39. Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer

40. Pan-cancer proteogenomics connects oncogenic drivers to functional states

41. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

42. Proteogenomic data and resources for pan-cancer analysis

45. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients—A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT

46. Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy

47. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

49. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination

50. DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway

Catalog

Books, media, physical & digital resources